CRISPR approach could limit toxicity of CAR-T therapy in AML
New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...
Protein inhibits inflammatory response underlying chronic pain processing; may provide an alternative to opioids for severe, persistent pain...
Researchers have created a tool that may help them to uncover why only a fraction of patients responds to new immune-based treatments...
A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic cancer earlier...
An international team of scientists has discovered that one of the biggest hitters in the immune system, macrophages, provide a cradle for mammary stem cells...
Researchers have discovered that a signalling protein elevated in patients with AML plays a much wider role in the disease than previously thought...
Researchers have found mEAK-7 regulates the molecular process that dictates cell growth and human development...
Researchers are reporting an innovative new method to screen for potential cancer drugs...
A new technique that uses tiny elastic balls filled with fluorescent nanoparticles aims to expand the understanding of the mechanical forces that exist between cells...
Cancer researchers have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers...
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
A CAR-T-based immunotherapy successfully kills tumours and prevents metastatic growth, in final preclinical tests before human trials...
Scientists have investigated the mechanisms by which the lymphatic endothelial cells modulate metastasis in melanoma, providing new targets for therapy development.
This article focuses on how the immune system functions, the challenges that it presents to drug development and why there are such concerns around safety that need to be investigated in pre-clinical studies. Moreover, it covers the role of checkpoint inhibitors as an attractive target for cancer immunotherapy.
Scientists use data from human cancers and C. elegans to understand mutational causes of cancer...